Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49

United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

Add to watchlist

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Troy Edward Wilson

President and CEO

—

914,650

$9.83M

+226.5%

Teresa Brophy Bair

Chief Legal Officer

—

187,002

$2.01M

+156.9%

Kathleen Ford

Chief Operating Officer

—

142,986

$1.54M

+14.1%

Thomas James Doyle

SVP, Finance & Accounting

—

142,928

$1.54M

+159.8%

Mollie Leoni

Chief Medical Officer

—

141,095

$1.52M

+200.4%

Brian T. Powl

Chief Commercial Officer

—

136,819

$1.47M

+772.7%

Francis Burrows

Chief Scientific Officer

—

42,327

$454.96K

+67.6%

Faheem Hasnain

Director

—

23,983

$257.79K

0.0%

Thomas Malley

Director

—

10,000

$107.49K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Kura Oncology, Inc.

What the insiders did No buying or selling

By person